Prediction of Long-Term Treatment Outcomes for Diabetic Macular Edema Using a Generative Adversarial Network-Reference-Cited by-同舟云学术

Prediction of Long-Term Treatment Outcomes for Diabetic Macular Edema Using a Generative Adversarial Network

Published:2024-07-03 Issue:7 Volume:13 Page:4
ISSN:2164-2591
Container-title:Translational Vision Science & Technology
language:en
Short-container-title:Trans. Vis. Sci. Tech.

Author:

Baek Jiwon¹²³⁴,He Ye¹⁴,Emamverdi Mehdi¹⁴,Mahmoudi Alireza¹⁴,Nittala Muneeswar Gupta¹,Corradetti Giulia¹⁴,Ip Michael¹⁴,Sadda SriniVas R.¹⁴

Affiliation:

1. Doheny Eye Institute, Pasadena, CA, USA

2. Department of Ophthalmology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Gyeonggi-do, Republic of Korea

3. Department of Ophthalmology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

4. Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Reference33 articles.

1. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis;Teo;Ophthalmology,2021

2. Persistent macular thickening following intravitreous aflibercept, bevacizumab, or ranibizumab for central-involved diabetic macular edema with vision impairment: a secondary analysis of a randomized clinical trial;Bressler;JAMA Ophthalmol,2018

3. Persistent macular thickening following intravitreous aflibercept, bevacizumab, or ranibizumab for central-involved diabetic macular edema with vision impairment: a secondary analysis of a randomized clinical trial;Bressler;JAMA Ophthalmol,2018

4. Effect of initial management with aflibercept vs laser photocoagulation vs observation on vision loss among patients with diabetic macular edema involving the center of the macula and good visual acuity: a randomized clinical trial;Baker;JAMA,2019

5. Intravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studies;Brown;Ophthalmology,2015